Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DR26F8N0B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,002
Award facts
- Contract value 100% obligated
- $14,001.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded November 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with a ceiling value of $14,001.90 and a firm fixed price structure. The award is not set-aside and represents a competitively awarded transaction under the company's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains a $999,999,999.00 prime IDC designated SPE2DX that extends through December 2026, enabling comprehensive pharmaceutical supply support to military healthcare programs globally.
This delivery order falls under the company's existing pharmaceutical supply arrangement with the DLA and represents one of numerous transactions for specialized medications including brand-name drugs, generics, vaccines, and medical supplies across multiple therapeutic domains. The performance location is identified as Conshohocken, Pennsylvania, with an ultimate completion date of November 19, 2025. As a child contract under AmerisourceBergen's prime vehicle, this award demonstrates the company's ongoing role in supporting Defense Health Agency operations and other federal healthcare systems through the flexible, comprehensive pharmaceutical vendor model that DLA employs for military medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F8N0B?
SPE2DR26F8N0B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F8N0B worth?
The government has obligated $14,002 on SPE2DR26F8N0B.
Is contract SPE2DR26F8N0B an order under another contract?
Yes. SPE2DR26F8N0B is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8N0B competed?
The extent of competition for SPE2DR26F8N0B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award